Contact
searchSearch
HMP Global

Q&As

Neda Shahriari, MD
Q&As
Depressive Symptoms and Psoriasis Systemic Treatment
04/04/2022
To discuss her study on depressive symptoms and psoriasis systemic treatment, The Dermatologist met with lead author Neda Shahriari, MD.
To discuss her study on depressive symptoms and psoriasis systemic treatment, The Dermatologist met with lead author Neda Shahriari, MD.
To discuss her study on...
04/04/2022
The Dermatologist
Matt Zirwas, MD
Q&As
Treating Hand Eczema
02/18/2022
There are 3 main types of hand eczema, although many other types have been theorized, and some may be challenging to treat.
There are 3 main types of hand eczema, although many other types have been theorized, and some may be challenging to treat.
There are 3 main types of hand...
02/18/2022
The Dermatologist
Saakshi Khattri, MD
Q&As
Dr Khattri on Risankizumab for Psoriatic Arthritis: Updates and Insights
02/16/2022
In this exclusive interview with The Dermatologist, Saakshi Khattri, MD, discusses what the risankizumab-rzaa approval means for clinicians and the psoriatic disease community.
In this exclusive interview with The Dermatologist, Saakshi Khattri, MD, discusses what the risankizumab-rzaa approval means for clinicians and the psoriatic disease community.
In this exclusive interview with...
02/16/2022
The Dermatologist
Celia Mead, Executive Director of BIRD
Q&As
Bath Institute for Rheumatic Diseases: Empowering Psoriatic Arthritis Researchers and Patients Alike
01/11/2022
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director...
01/11/2022
The Dermatologist
Dr Craig Leonardi
Q&As
Dr Craig Leonardi on Emerging Anti-IL-17 Biologic, Bimekizumab
12/08/2021
Dr Leonardi discusses the latest evidence regarding bimekizumab, a novel biologic that inhibits both IL-17A and IL-17F, from a poster presented at the Academy of Managed Care Pharmacy Nexus 2021.
Dr Leonardi discusses the latest evidence regarding bimekizumab, a novel biologic that inhibits both IL-17A and IL-17F, from a poster presented at the Academy of Managed Care Pharmacy Nexus 2021.
Dr Leonardi discusses the latest...
12/08/2021
The Dermatologist
lead author Benjamin Ungar, MD
Q&As
How an Atopic Dermatitis Biologic May Improve COVID-19 Outcomes
11/29/2021
A recently published study found that patients with atopic dermatitis on dupilumab experienced better COVID-19 outcomes. Study authors Drs Emma Guttman and Benjamin Ungar discuss the results.
A recently published study found that patients with atopic dermatitis on dupilumab experienced better COVID-19 outcomes. Study authors Drs Emma Guttman and Benjamin Ungar discuss the results.
A recently published study found...
11/29/2021
The Dermatologist
Naimish Patel, MD, head of global development, immunology and inflammation at Sanofi Genzyme discussed atopic dermatitis.
Q&As
Updates on Dupilumab: Atopic Dermatitis in Children as Young as 6 Months
11/15/2021
The results of a pivotal phase 3 trial of dupilumab brings updates in treating children aged 6 months to 5 years with moderate to severe atopic dermatitis.
The results of a pivotal phase 3 trial of dupilumab brings updates in treating children aged 6 months to 5 years with moderate to severe atopic dermatitis.
The results of a pivotal phase 3...
11/15/2021
The Dermatologist
John Barbieri, MD, MBA, is a leading expert on acne (such as cystic acne), and acne treatment sharing insights on pimples.
Q&As
Acne and Treatment Updates
11/11/2021
Dr John Barbieri met with The Dermatologist to discuss his insights into acne and its treatment updates on the horizon.
Dr John Barbieri met with The Dermatologist to discuss his insights into acne and its treatment updates on the horizon.
Dr John Barbieri met with The...
11/11/2021
The Dermatologist
Nikki Longwell PhD
Q&As
National Biologic Coordinator’s Day: Q&A With Dr Nikki Longwell
11/04/2021
On November 1, 2021, the first National Biologic Coordinator’s Day took place in the United States. The initiative, established by Janssen, highlights the important role of these staff members of dermatology practices across the...
On November 1, 2021, the first National Biologic Coordinator’s Day took place in the United States. The initiative, established by Janssen, highlights the important role of these staff members of dermatology practices across the...
On November 1, 2021, the first...
11/04/2021
The Dermatologist
Q&As
Insights Into Basal Cell Carcinoma Gene Mutations
10/12/2021
Dr Ashley Wysong shares her insights on basal cell carcinoma gene mutations and how these affect patients with skin of color in comparison with White patients in the United States.
Dr Ashley Wysong shares her insights on basal cell carcinoma gene mutations and how these affect patients with skin of color in comparison with White patients in the United States.
Dr Ashley Wysong shares her...
10/12/2021
The Dermatologist
Nov/Dec 2024 Cover

Current Issue

December 2024
Volume 32
Issue 8
Current Issue
Issue Archive

Popular Articles

combined clinics - handshake
Conference Coverage
Combined Clinics – Treating Patients as a Whole
04/22/2022
Dr Joseph F Merola, MD, MMSc and Dr Alexis Ogdie, MD, MSCE got together to discuss combined clinics touched base on “accessing the role of interdisciplinary care in optimizing disease outcomes and then understanding how combined approaches to...
Dr Joseph F Merola, MD, MMSc and Dr Alexis Ogdie, MD, MSCE got together to discuss combined clinics touched base on “accessing the role of interdisciplinary care in optimizing disease outcomes and then understanding how combined approaches to...
Dr Joseph F Merola, MD, MMSc and...
04/22/2022
The Dermatologist
Ethnic Skin and Hair
A Closer Look at Keloids
09/04/2008
Keloids are abnormal scars characterized by excessive scar tissue formation. Clinically, these elevated scars demonstrate extension beyond the original border of the wound. Hypertrophic scars differ from keloids in that they remain within the...
Keloids are abnormal scars characterized by excessive scar tissue formation. Clinically, these elevated scars demonstrate extension beyond the original border of the wound. Hypertrophic scars differ from keloids in that they remain within the...
Keloids are abnormal scars...
09/04/2008
The Dermatologist
Brett King, MD, PhD
Conference Coverage
The Pathogenesis and Treatment of Alopecia Areata
05/12/2022
During his session presented at Dermatology Week 2022, Brett King, MD, PhD, discussed the lack of effective treatment for alopecia areata, and recent data on utilizing JAK inhibitors.
During his session presented at Dermatology Week 2022, Brett King, MD, PhD, discussed the lack of effective treatment for alopecia areata, and recent data on utilizing JAK inhibitors.
During his session presented at...
05/12/2022
The Dermatologist
Letters to the Editor
Another Name for a Useful Flap
09/04/2008
W e’re writing to offer a simpler name that we use to describe the closure illustrated by Dr. Lance Brown’s "Surgical Challenge" column, which debuted in your February 2003 issue. Although the repair is accurately described as...
W e’re writing to offer a simpler name that we use to describe the closure illustrated by Dr. Lance Brown’s "Surgical Challenge" column, which debuted in your February 2003 issue. Although the repair is accurately described as...
W e’re writing to offer a...
09/04/2008
The Dermatologist
News
Risankizumab Shows Comparable Safety and Efficacy Profiles in Patients With Psoriasis
06/08/2022
Researchers aimed to perform a real-life study to compare indirect efficacy and safety of anti-IL23s.
Researchers aimed to perform a real-life study to compare indirect efficacy and safety of anti-IL23s.
Researchers aimed to perform a...
06/08/2022
The Dermatologist

Subscribe

The Dermatologist Newsletter

Latest Quizzes and Trivia

Illustration of JAK1 Protein
Quiz
Test Your Knowledge: The Immunology of JAK Inhibitors
12/05/2024
12/05/2024
The Dermatologist
Gil Yosipovitch, MD
Quiz
Long-Term Efficacy of Dupilumab for Prurigo Nodularis
12/05/2024
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed to better understand the long-term efficacy of dupilumab for prurigo nodularis?
What future research is needed...
12/05/2024
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use